Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Ulcer 1Tomaculous neuropathy 1Thrombocythemia, Essential 1Stomatitis 1Stomach Neoplasms 1Radiation Pneumonitis 1Primary Myelofibrosis 1Polycythemia Vera 1Polycystic Ovary Syndrome 1Neuroma 1Myeloproliferative Disorders 1Median Neuropathy 1Lung Neoplasms 1Lung Diseases, Interstitial 1Hand Injuries 1Disease 1Carpal Tunnel Syndrome 1Breast Neoplasms 1

Interventions

Metformin 7Exercise 4Inositol 3semaglutide 2Tablets 2Spironolactone 2Progesterone 2xin-kang 1mirabegron 1mazdutide 1maltodextrin 1drospirenone 1dapagliflozin 1artenimol 1Water 1Vitamin D 1Transcranial Direct Current Stimulation 1Tirzepatide 1Thyroxine 1Thioctic Acid 1Sitagliptin Phosphate 1Quercetin 1Physical Examination 1Observation 1Magnesium 1Liraglutide 1Letrozole 1Ketones 1In Vitro Oocyte Maturation Techniques 1Hydroquinones 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Polycystic Ovary Syndrome × Acetylcysteine × Clear all
NCT06836128 2025-07-09

PCOS

Cairo University

Phase 3 Recruiting
102 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡